Mulvihill Capital Management Inc. Announces Special Meeting of Mulvihill U.S. Health Care Enhanced Yield ETF
October 25 2024 - 5:55PM
(TSX: XLVE) Mulvihill Capital
Management Inc. (the “
Manager”), the manager of
Mulvihill U.S. Health Care Enhanced Yield ETF (the
“
Fund”) announced today that the board of
directors of the Manager has approved a proposal to (i) change the
focus of the Fund from equities of U.S. healthcare companies to
primarily listed preferred shares of Canadian split share
corporations; (ii) change the name of the Fund to “Mulvihill
Enhanced Split Preferred Share ETF”; and (iii) consolidate the
exchange-traded units (the “
Units”) of the Fund in
order to reset the net asset value per Unit to $10.00 per Unit
(collectively, the “
Proposal”), all as more
particularly described in the management information circular (the
“
Circular”) for the special meeting (the
“
Meeting”) of the Fund’s unitholders (the
“
Unitholders”). In connection with the Proposal,
the Fund’s ticker symbol will be changed to “SPFD” from “XLVE”.
The purpose of the Meeting is to consider and
vote upon the Proposal.
The Manager believes that the Proposal will be
beneficial for the Fund. Canadian split corporation preferred
shares rank in priority to common equity and are generally backed
by a portfolio of large capitalization dividend producing Canadian
and/or global equity securities across several sectors including
financials, real estate and energy. Changing the focus of the Fund
from equities of U.S. healthcare companies to listed preferred
shares of Canadian split share corporations should enable the Fund
to grow its assets under management and lower its management
expense ratio for the benefit of all Unitholders. Additionally, the
Manager wants to be in a position to offer a less volatile, more
steady cash flow producing exchange-traded fund. Preferred shares
of Canadian split share corporations listed on a Canadian exchange
with a fixed term are attractive in the current market in the
context of potential declining interest rates.
The board of directors of the Manager of the
Fund has unanimously approved the Proposal and recommends that the
Unitholders vote FOR the Proposal. The independent review committee
of the Fund has provided a positive recommendation in favour of the
Proposal.
A special meeting of the Unitholders has been
called and will be held virtually on November 29, 2024 with the
close of business on October 28, 2024 as the record date (the
“Record Date”) for the Meeting. The Meeting is
scheduled to be held as a virtual-only meeting conducted via live
audio webcast online on November 29, 2024 at 10:00 a.m. (Eastern
time). Unitholders, regardless of geographic location, will have an
equal opportunity to participate in the Meeting online. Unitholders
will not be able to attend the Meeting in person. Unitholders of
record as of the close of business on the Record Date are entitled
to receive notice of and vote at the Meeting. Unitholders are urged
to vote well before the proxy deadline of 5:00 p.m. (Eastern time)
on November 27, 2024.
In order for the Proposal to become effective,
the Proposal must be approved by at least a majority of votes cast
at the Meeting by Unitholders. The Proposal is also subject to
regulatory approval.
The Circular is being mailed to Unitholders in
compliance with applicable laws, and will be available under the
Fund’s profile on SEDAR+ at www.sedarplus.com. The Circular
provides important information on the Proposal and related matters,
including the voting procedures and how to virtually attend the
Meeting. Unitholders are urged to read the Circular and its
schedules carefully and in their entirety.
For further information, please contact Investor
Relations at 416.681.3966, toll free at 1-800-725-7172 or visit
www.mulvihill.com.
John Germain, Senior Vice-President & CFO |
Mulvihill Capital
Management Inc.121 King Street
West Suite 2600Toronto, Ontario, M5H 3T9 416.681.3966;
1.800.725.7172www.mulvihill.com info@mulvihill.com |
|
You will usually pay brokerage fees to your
dealer if you purchase or sell Units of the Fund on the TSX. If the
Units are purchased or sold on the TSX, investors may pay more than
the current net asset value when buying and may receive less than
current net asset value when selling them. There are ongoing fees
and expenses associated with owning Units of the Fund. An
investment fund must prepare disclosure documents that contain key
information about the Fund. You can find more detailed information
about the Fund in these documents. Investment funds are not
guaranteed, their values change frequently and past performance may
not be repeated.
Mulvihill US Health Care... (TSX:XLVE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Mulvihill US Health Care... (TSX:XLVE)
Historical Stock Chart
From Dec 2023 to Dec 2024